Pharmaceutical Technology

MAY 2, 2023

While initially only approved for metastatic disease, ICIs have now moved into earlier disease settings, reducing the risk of disease progression and relapse. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000.

Immunity 52

Immunity Immunization Vaccines 52

PharmD Live

DECEMBER 21, 2021

With an annual price per patient of nearly $56,000 per year, patients’ families are looking for solutions for their loved ones–with a huge price tag. New Standard for Blood Pressure in Chronic Kidney Disease. Practitioners are cautious about its effectiveness, and Medicare has not decided whether to include it in its formulary.

Diabetes 52

Diabetes Hospitals 52

pharmaphorum

JUNE 2, 2022

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. As covered in a previous article , the importance of R&D to develop treatments for rare diseases is high. of the global population are affected by a rare disease.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

pharmaphorum

JANUARY 21, 2022

Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 31, 2023

Given the high price tags placed on many medications, it’s easy to understand why patients often feel that they are being taken advantage of. As pharmaceutical companies embrace digital solutions that engage patients, we expect to see a boom in patients becoming more empowered partners in managing their conditions (Participatory Health).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 52

epicur

MAY 16, 2024

In ophthalmology, you get to do: Internal Medicine: Systemic workups for diseases that you can detect in the eye, like high blood pressure, some types of cancer, and even detect hormonal imbalances in the eye. Dermatology: Allergies affecting the eyes and even some allergic skin diseases around the eye. How did you first start that?

Compounding 52

Compounding Hospitals 52

pharmaphorum

JUNE 8, 2021

The FDA “has failed in its responsibility to protect patients and families from unproven treatments with known harms” in approving Biogen’s Alzheimer’s disease drug Aduhelm. The post FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag appeared first on.

Labelling 98

Labelling Drug Pricing 98

FDA Law Blog: Biosimilars

JUNE 27, 2023

Amongst his accomplishments, Law360 considered the role James has played in leveraging little-used pathways to FDA approval for often first-ever drugs to treat rare diseases (e.g., Duchenne, Friederichs’s Ataxia, Sickle Cell Disease, Chagas, ALS). Dormer Jeffrey N. Gibbs Paul M.

Drug Development 81

Drug Development Pharmaceutical Manufacturing 81

PharmaShots

MARCH 10, 2023

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes Date: Mar 10, 2023 | Tags: Vertex, VX-264, Type 1 Diabetes, Regulatory, US, FDA, IND Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies Date: Mar 10, 2023 | Tags: Alnylam, Medison Pharma, RNAi Therapies, Onpattro, patisiran, (..)

Diabetes 40

Diabetes Biosimilars Vaccines 40

PharmaShots

MARCH 9, 2023

Education: She graduated from Cornell University with a master’s in Business Administration and Management. She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 28, 2022

Innovation thrives in collaboration, not in isolation – and the open sourcing of Substra is a landmark moment in the use of collaborative AI in medical research,” Ibrahim Haddad, general manager of the LF AI & Data Foundation, said in a statement.

Hospitals 72

Hospitals Drug Development 72

pharmaphorum

FEBRUARY 16, 2021

In this first draft guidance NICE raised a series of issues with Zynteglo, which bluebird has already agreed to supply at a confidential discount from its hefty price tag, which is around €1.57 The thing that baffled me most was the lack of understanding of this disease upon the people living with it.”. million in Europe.

72

72

pharmaphorum

FEBRUARY 26, 2021

Some of the most well-known Janssen products include diarrhoea treatment, Immodium (loperamide), antipsychotic Risperdal (risperidone) and Alzheimer’s disease drug, Reminyl (galantamine). During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. billion in cash.

Vaccines 124

Vaccines Biosimilars Labelling Diabetes 124

pharmaphorum

OCTOBER 4, 2022

However, one of the early challenges that faced the Biobank on being set up was the difficulty in managing the volume of data that would be produced. The biospecimens and associated health data will then be made available to cancer scientists, potentially offering the opportunity to discover new treatments.

Documentation 102

Documentation HIPAA Data Entry 102

The Physician Pharmacist

SEPTEMBER 14, 2023

However, a lot of the time the physicians name tags will just say physician you won't even know if they're an MD or do there's actually been a few times I remember from happiness where the physicians and techs at MD and I looked them up to see where they went to school and they went to an osteopathic medical school. I know some people do.

Medical Schools 52

Medical Schools Hospitals Communication 52

European Pharmaceutical Review

DECEMBER 27, 2023

Bridging therapy has been shown to correlate with an inferior response to CAR T-cell therapy due to both progression of the chemotherapy-refractory malignant disease during the manufacturing period and increased toxicity. This is in addition to its considerable price tag. 2021;138(24):2499–513. Schultz LM, Baggott C, Prabhu S, et al.

Adverse Reactions 83

Adverse Reactions Immunity Immunization Medical Schools 83

Pharmaceutical Technology

NOVEMBER 30, 2022

In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In 1997, the World Health Organization (WHO) classified obesity as a chronic disease. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98